Hormonally active vitamin D3 – 1,25‐dihydroxyvitamin D3 (1,25D3) – acts as a signalling molecule in cutaneous immunity. In this study we investigated if Toll‐like‐receptor (TLR) function and antimicrobial peptide (AMP) expression are controlled by 1,25D3 in keratinocytes. The AMP cathelicidin and TLR cofactor CD14 were known to be induced by 1,25D3, and analysis of TLR2 expression revealed this also was increased by 1,25D3. Topical 1,25D3 application to human skin confirmed these results, showing increased cathelicidin, CD14 and TLR2 by immunostaining. Furthermore, the presence of 1,25D3 enabled human keratinocytes to respond to Malp2 (a TLR2/6 ligand) with increased cathelicidin production which was inhibited by neutralizing antibody to TLR2. 1,25D3 also increased the ability of keratinocytes to kill Staphylococcus aureus. Interestingly, keratinocytes surrounding human skin wounds increased expression of CD14 and showed a previously known increase in cathelicidin AMP. Thus, we hypothesized that 1,25D3 was also a signalling molecule during skin injury. Supporting this, we found that CYP27B1, the enzyme that converts 25‐hydroxy vitamin D3 (25D3) to active 1,25D3, was significantly increased in wounds and induced in response to factors in the wound micromilieu such as TGFβ1 or TLR stimulation. Blocking the vitamin D receptor, inhibiting CYP27B1 enzymatic activity, or limiting 25D3 in culture each prevented TGFβ1 from inducing cathelicidin, CD14 or TLR2. Furthermore, mice deficient in CYP27B1 failed to increase CD14 in vivo following injury. Thus, this investigation demonstrates how injury initiates the innate immune response; 25D3 is activated to 1,25D3 by enzymatic conversion, a process triggered by microbial products or host factors such as TGFβ1. The increase in 1,25D3 then directly increases cathelicidin release and enables responsiveness to microbial products through induction of TLR cofactor CD14.
Read full abstract